PRETE, ALESSANDRA ANNA
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 110
AS - Asia 95
SA - Sud America 1
Totale 696
Nazione #
US - Stati Uniti d'America 490
IT - Italia 75
CN - Cina 56
SG - Singapore 34
FI - Finlandia 8
DE - Germania 5
GB - Regno Unito 4
NL - Olanda 4
FR - Francia 3
SE - Svezia 3
TR - Turchia 3
UA - Ucraina 3
AT - Austria 2
ES - Italia 2
IN - India 2
BR - Brasile 1
RU - Federazione Russa 1
Totale 696
Città #
Fairfield 89
Chandler 63
Ann Arbor 35
Ashburn 35
Houston 32
Woodbridge 29
Seattle 26
Singapore 26
Wilmington 22
Cambridge 21
Santa Clara 21
Beijing 15
Boardman 14
Padova 11
Los Angeles 8
Medford 8
Princeton 8
Cagliari 6
Des Moines 6
Helsinki 6
Milan 6
San Diego 6
Guangzhou 3
Rome 3
Ankara 2
Boydton 2
Caponago 2
Ferrara 2
Gazzo 2
Genoa 2
Grosseto 2
Hounslow 2
Lancenigo-Villorba 2
Lappeenranta 2
Recco 2
Trieste 2
Albignasego 1
Bollate 1
Cangzhou 1
Cesena 1
Chengdu 1
Chongqing 1
Frankfurt am Main 1
Haikou 1
Hanover 1
Jinan 1
Kharkiv 1
Kilburn 1
Kunming 1
Lavis 1
Madrid 1
Mumbai 1
Nanchang 1
North Wales 1
Pinerolo 1
Prescot 1
Shenyang 1
Stefania 1
São Paulo 1
Venice 1
Wuhan 1
Xian 1
Totale 549
Nome #
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 130
Immunotherapy in Gastrointestinal Cancers 128
Immunotherapy in Gastrointestinal Cancers 120
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 67
Profiling molecolare esteso del carcinoma anale a cellule squamose nella popolazione di uno studio di fase 2: analisi traslazionali dello studio “CARACAS”. 64
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes 53
The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors 43
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 36
Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy 33
HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study 29
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study 19
Totale 722
Categoria #
all - tutte 3.999
article - articoli 3.800
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 0 0 18 17 17 11 10 13
2020/202179 2 11 1 8 1 7 1 14 7 9 10 8
2021/2022100 1 10 4 11 8 6 8 9 15 0 4 24
2022/2023109 18 13 2 23 16 10 1 8 11 3 4 0
2023/2024115 0 19 10 6 8 12 14 12 4 13 10 7
2024/2025117 2 16 12 25 40 21 1 0 0 0 0 0
Totale 722